Previous   Next
HomeBusinessDGCI Approves For Phase 3 Trial of Bharat Biotech Intranasal Vaccine As...

DGCI Approves For Phase 3 Trial of Bharat Biotech Intranasal Vaccine As Booster

Drug Controller General of India (DGCI) on Wednesday granted “in principle” approval to Bharat Biotech to conduct “Phase III superiority study and Phase III booster dose study” trials for its intranasal Covid vaccine. The approval was sought by the vaccine manufacturer last week.

Subject Experts Committee (SEC) has asked the company to submit the protocol for booster study.

On Tuesday, the Committee held a meeting to discuss the vaccine manufacturer Bharat Biotech’s application for clinical trials of its intranasal Covid vaccine as a booster.

The Hyderabad-based manufacturer had proposed the booster dose for those who have been already been inoculated with Covishield and Covaxin vaccines.

According to a source, Bharat Biotech aims to conduct clinical trials on 5,000 healthy subjects: half or 2,500 individuals who have received Covishield and another 2,500 who have been administered Covaxin.

There will be a gap of around six months between the second and the intranasal booster dose. The source said that the nasal booster vaccine is likely to be launched in India by March following clinical trials.

In his address to the nation on December 25, Prime Minister Narendra Modi had assured that soon the country will develop a nasal vaccine.

More News

Eknath Shinde Will Be New Chief Minister of Maharashtra: Devendra Fadnavis

Eknath Shinde will be the new Chief Minister of Maharashtra, said BJP leader Devendra Fadnavis during a press conference on Thursday. The announcement came...

Coronavirus: India Reports 14,506 New Covid Cases

India logged 14,506 new coronavirus cases in the last 24 hours, taking the total number of COVID-19 cases to 4,34,33,345. According to the Union...

Russian Prez Is Getting ‘Exactly What He Didn’t Want’: US Prez

US President Joe Biden on Wednesday said Russian President Vladimir Putin is getting ‘exactly what he didn’t want’ the NATO-nation of Europe, the media...


Akash Ambani Is The New Chairman of Reliance Jio

Mukesh Ambani’s son, Akash Ambani, was named chairman of the board at Reliance Jio on Tuesday, signaling a transition in leadership for one of...

G7 Agrees To Explore Imposing A Ban On Transporting Russian Oil

The Group of Seven economic powers has agreed to explore imposing a ban on transporting Russian oil that has been sold above a certain...

Sensex Rises 433 Points, Nifty Settles At 15,832

The Benchmark indices ended higher for the third straight session on June 27 with Nifty above 15800 amid buying across the sectors. At close, the...